Jiangsu Apon Epson Pharmaceutical

Jiangsu Apon Pharmaceutical is a specialized pharmaceutical company based in China and a core subsidiary of the publicly traded Jiangsu Apon Medical Technology (SZ: 300753). Formerly known as Jiangsu Epson Pharmaceutical, the company focuses on the development and manufacture of high-quality medications for anesthesia, pain management, and emergency care. Its commercial portfolio features essential treatments such as Naloxone Hydrochloride for opioid overdose reversal and Flumazenil for benzodiazepine reversal, alongside various analgesics like Butorphanol and Nefopam. The company integrates its pharmaceutical products with its parent's expertise in medical devices, particularly patient-controlled analgesia (PCA) pumps, to offer comprehensive clinical solutions. Operating from GMP-certified facilities in Jiangsu, the company serves both domestic and international markets with a focus on perioperative safety and acute pain relief.